Cargando…

Different levels of hypoglycemia in patients with type 2 diabetes, their achieved mean HbA1c vs. all-cause and cardiovascular mortality

AIM: In patients with type 2 diabetes (T2D), levels of hypoglycemia and their risk of mortality are not well understood. The aim of this study was to ascertain the correlation among disparate levels of hypoglycemia and patients with T2D’s achieved mean glycated hemoglobin A1c (HbA1c) with all-cause...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ooi, Seng-Wei, Yeh, Shu-Tin, Chang, Ya-Hui, Li, Chung-Yi, Chen, Hua-Fen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370691/ https://www.ncbi.nlm.nih.gov/pubmed/37494344 http://dx.doi.org/10.1371/journal.pone.0288360

Ejemplares similares

Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages
por: Ooi, Seng-Wei, et al.
Publicado: (2022)

The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study
por: Chang, Chin-Huan, et al.
Publicado: (2023)

Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes
por: Yeh, Shu-Tin, et al.
Publicado: (2022)

HbA(1c) and the Risks for All-Cause and Cardiovascular Mortality in the General Japanese Population: NIPPON DATA90
por: Sakurai, Masaru, et al.
Publicado: (2013)

Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023)

Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study
por: Tan, Joshua Kuan, et al.
Publicado: (2023)

HbA(1c) and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes and Aging Study
por: Lipska, Kasia J., et al.
Publicado: (2013)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes
por: Bron, Morgan, et al.
Publicado: (2014)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

Association of Low Fasting Glucose and HbA1c With Cardiovascular Disease and Mortality: The MESA Study
por: Mongraw-Chaffin, Morgana, et al.
Publicado: (2019)

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Point-of-Care Measurements of HbA(1c): Simplicity Does Not Mean Laxity With Controls
por: Leca, Viviane, et al.
Publicado: (2012)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Personality as a predictor of HbA1c level in patients with type 2 diabetes mellitus
por: Lee, Shu-Fen, et al.
Publicado: (2021)

Elevated HbA1c is not associated with recurrent venous thromboembolism in the elderly, but with all-cause mortality– the SWEETCO 65+ study
por: Mathis, Alexandra, et al.
Publicado: (2020)

Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2021)

Association of Mean and Variability of HbA1c with Heart Failure in Patients with Type 2 Diabetes
por: Lin, You-Ting, et al.
Publicado: (2021)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program
por: Allen, Sheryl Elaine, et al.
Publicado: (2022)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population
por: Hernandez, Domingo, et al.
Publicado: (2013)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
por: Tsujino, Daisuke, et al.
Publicado: (2016)

Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus
por: Long, Chen, et al.
Publicado: (2022)

A Study Assessing the Association of Glycated Hemoglobin A(1C) (HbA(1C)) Associated Variants with HbA(1C), Chronic Kidney Disease and Diabetic Retinopathy in Populations of Asian Ancestry
por: Chen, Peng, et al.
Publicado: (2013)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Association of HbA1c Values with Mortality and Cardiovascular Events in Diabetic Dialysis Patients. The INVOR Study and Review of the Literature
por: Sturm, Gisela, et al.
Publicado: (2011)

Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments
por: Møller, J B, et al.
Publicado: (2013)

Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
por: Cha, Seon-Ah, et al.
Publicado: (2016)

The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7%
por: Wang, Junmei, et al.
Publicado: (2022)

Interaction between Mean Arterial Pressure and HbA1c in Prediction of Cardiovascular Disease Hospitalisation: A Population-Based Case-Control Study
por: Yu, Dahai, et al.
Publicado: (2016)

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC
por: Agilli, Mehmet, et al.
Publicado: (2013)

Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point
por: Chamnan, P., et al.
Publicado: (2013)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
por: Billings, LK, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ifond46otlul7u00vijo5hdu35